会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Methods of inhibiting ECM accumulation in the CNS by inhibition of
TGF-.beta.
    • 通过抑制TGF-β抑制CNS中ECM积累的方法
    • US5958411A
    • 1999-09-28
    • US410573
    • 1995-03-24
    • Ann LoganAndrew Baird
    • Ann LoganAndrew Baird
    • A61K38/00A61K38/04A61K38/17A61K38/18C07K16/22A61K38/16A61K39/395
    • C07K16/22A61K38/04A61K38/1709A61K38/1841
    • The present invention relates to methods for preventing, suppressing or treating a CNS pathology characterized by a deleterious accumulation of extracellular matrix in a tissue by contacting the tissue with an agent that inhibits the extracellular matrix producing activity of TGF-.beta.. The methods can be used to prevent, suppress or treat scar formation in the CNS. Agents that are useful in the present methods include neutralizing anti-TGF-.beta. antibodies, Arg-Gly-Asp-containing peptides, decorin and its functional equivalents such as biglycan, and TGF-.beta. antagonists. The present invention further provides methods for preventing, suppressing or treating a CNS pathology characterized by the insufficient accumulation of extracellular matrix. Agents that enhance the production of extracellular matrix, such as TGF-.beta., can be used in such methods. Finally, the present invention provides pharmaceutical compositions containing these agents, which can be administered to patients to inhibit or enhance the production of extracellular matrix in the CNS.
    • 本发明涉及用于预防,抑制或治疗CNS病理学的方法,其特征在于通过使组织与抑制TGF-β的细胞外基质产生活性的试剂接触将组织中的细胞外基质有害积累。 该方法可用于预防,抑制或治疗CNS中的瘢痕形成。 在本方法中有用的试剂包括中和抗TGF-β抗体,含Arg-Gly-Asp的肽,核心蛋白聚糖及其功能等同物如双糖链聚糖和TGF-β拮抗剂。 本发明还提供了预防,抑制或治疗以细胞外基质积累不足为特征的CNS病理学的方法。 可以使用增强细胞外基质如TGF-β产生的药剂。 最后,本发明提供含有这些试剂的药物组合物,其可以施用于患者以抑制或增强CNS中细胞外基质的产生。